DB-1202
/ DualityBio
- LARVOL DELTA
Home
Next
Prev
1 to 1
Of
1
Go to page
1
March 27, 2023
A Study of DB-1202 Monotherapy in Advanced Solid Tumors
(clinicaltrials.gov)
- P1/2 | N=150 | Not yet recruiting | Sponsor: DualityBio Inc.
Metastases • Monotherapy • New P1/2 trial • Oncology • Solid Tumor • PD-L1
1 to 1
Of
1
Go to page
1